Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jul 12 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-12-2024-6

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 12, 2024, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval Selexipag for Injection, 1,800 mcg/vial".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases